Department of Medical Biochemistry and Molecular Biology, University of Saarland Medical Center, D-66421 Homburg, Germany.
J Cell Biochem. 2013 Mar;114(3):681-96. doi: 10.1002/jcb.24410.
G-protein coupled designer receptors that are specifically activated by designer drugs have been developed. Here, we have analyzed the regulation of gene transcription following activation of Gα(q)-coupled designer receptor (Rα(q)). Stimulation of human embryonic kidney (HEK) 293 cells expressing Rα(q) with clozapine-N-oxide (CNO), a pharmacologically inert compound, induced the expression of biologically active Egr-1, a zinc finger transcription factor. Expression of a dominant-negative mutant of the ternary complex factor (TCF) Elk-1, a key transcriptional regulator of serum response element (SRE)-driven gene transcription, prevented Egr-1 expression. Stimulation of Rα(q) with CNO increased the transcriptional activation potential of Elk-1 and enhanced transcription of an SRE regulated reporter gene. In addition, AP-1 transcriptional activity was significantly elevated. AP-1 activity was controlled by TCFs and c-Jun in cells expressing an activated Gα(q)-coupled designer receptor. CNO stimulation did not increase Egr-1 and AP-1 activity in neuroblastoma cells expressing endogenous M3 muscarinic acetylcholine receptors, indicating that CNO did not function as a ligand for these receptors. Rα(q) stimulation also increased the transcriptional activation potential of CREB and cAMP response controlled gene transcription. Pharmacological and genetic experiments revealed that the protein kinases Raf and ERK were essential to connect Rα(q) stimulation with enhanced Egr-1 and AP-1 controlled transcription. In contrast, MAP kinase phosphatase-1 functioned as a nuclear shut-off device of stimulus-transcription coupling. The fact that Rα(q) stimulation activates the transcription factors Egr-1, Elk-1, AP-1, and CREB indicates that regulation of gene transcription is an integral part of Gα(q)-coupled receptor signaling.
已开发出可被设计药物特异性激活的 G 蛋白偶联设计受体。在这里,我们分析了 Gα(q) 偶联设计受体 (Rα(q)) 激活后基因转录的调节。用药理学上无活性的化合物氯氮平-N-氧化物 (CNO) 刺激表达 Rα(q) 的人胚肾 (HEK) 293 细胞,诱导生物活性 Egr-1 的表达,Egr-1 是一种锌指转录因子。表达关键转录调节剂血清反应元件 (SRE) 驱动基因转录的三元复合物因子 (TCF) Elk-1 的显性负突变体,可防止 Egr-1 的表达。用 CNO 刺激 Rα(q) 可增加 Elk-1 的转录激活潜力,并增强 SRE 调控的报告基因的转录。此外,AP-1 转录活性显著升高。在表达激活的 Gα(q) 偶联设计受体的细胞中,AP-1 活性受 TCFs 和 c-Jun 控制。CNO 刺激不会增加表达内源性 M3 毒蕈碱乙酰胆碱受体的神经母细胞瘤细胞中的 Egr-1 和 AP-1 活性,表明 CNO 不能作为这些受体的配体发挥作用。Rα(q) 刺激还增加了 CREB 的转录激活潜力和 cAMP 反应控制的基因转录。药理和遗传实验表明,蛋白激酶 Raf 和 ERK 对于将 Rα(q) 刺激与增强的 Egr-1 和 AP-1 控制的转录联系起来是必不可少的。相比之下,MAP 激酶磷酸酶-1 是刺激-转录偶联的核关闭装置。Rα(q) 刺激激活转录因子 Egr-1、Elk-1、AP-1 和 CREB 这一事实表明,基因转录的调节是 Gα(q) 偶联受体信号转导的一个组成部分。